71.65
1.26%
0.89
전일 마감가:
$70.76
열려 있는:
$70.7
하루 거래량:
7.89M
Relative Volume:
4.48
시가총액:
$16.26B
수익:
$4.03B
순이익/손실:
$789.50M
주가수익비율:
37.12
EPS:
1.93
순현금흐름:
$1.15B
1주 성능:
-2.72%
1개월 성능:
-8.19%
6개월 성능:
-0.78%
1년 성능:
+1.89%
홀로직 Stock (HOLX) Company Profile
명칭
Hologic Inc
전화
(508) 263-2900
주소
250 CAMPUS DRIVE, MARLBOROUGH, MA
HOLX을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
71.65 | 16.26B | 4.03B | 789.50M | 1.15B | 3.33 |
ISRG
Intuitive Surgical Inc
|
524.43 | 186.79B | 7.87B | 2.24B | 586.00M | 6.22 |
BDX
Becton Dickinson Co
|
227.68 | 65.83B | 20.18B | 1.71B | 3.07B | 5.94 |
ALC
Alcon Inc
|
84.76 | 41.92B | 9.76B | 1.16B | 665.00M | 2.34 |
RMD
Resmed Inc
|
237.27 | 34.83B | 4.81B | 1.11B | 1.35B | 7.55 |
WST
West Pharmaceutical Services Inc
|
331.40 | 24.00B | 2.88B | 499.60M | 321.60M | 6.74 |
홀로직 Stock (HOLX) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-12-13 | 개시 | Wolfe Research | Peer Perform |
2024-12-10 | 개시 | Jefferies | Hold |
2024-12-10 | 재확인 | Needham | Buy |
2024-10-01 | 다운그레이드 | Citigroup | Buy → Neutral |
2024-06-27 | 개시 | Stephens | Overweight |
2024-04-03 | 업그레이드 | Citigroup | Neutral → Buy |
2023-07-14 | 업그레이드 | Needham | Hold → Buy |
2022-12-07 | 개시 | RBC Capital Mkts | Sector Perform |
2022-10-13 | 개시 | Mizuho | Buy |
2022-07-20 | 다운그레이드 | BofA Securities | Buy → Neutral |
2022-07-20 | 개시 | UBS | Neutral |
2022-07-18 | 다운그레이드 | BTIG Research | Buy → Neutral |
2022-04-25 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
2022-04-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
2021-12-15 | 다운그레이드 | Citigroup | Buy → Neutral |
2021-10-15 | 재개 | Cowen | Outperform |
2021-10-14 | 개시 | Redburn | Neutral |
2021-07-06 | 업그레이드 | Evercore ISI | In-line → Outperform |
2020-11-20 | 다운그레이드 | Needham | Buy → Hold |
2020-11-05 | 재확인 | Needham | Buy |
2020-06-30 | 업그레이드 | Cowen | Market Perform → Outperform |
2020-06-03 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
2020-04-30 | 재확인 | Needham | Buy |
2020-04-30 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
2020-04-07 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
2020-03-27 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
2020-01-13 | 재확인 | Needham | Buy |
2020-01-08 | 개시 | Wells Fargo | Equal Weight |
2020-01-07 | 개시 | Citigroup | Buy |
2020-01-02 | 다운그레이드 | Evercore ISI | Outperform → In-line |
2019-09-26 | 업그레이드 | BofA/Merrill | Neutral → Buy |
2019-08-01 | 재확인 | Needham | Buy |
2019-05-02 | 재확인 | Needham | Buy |
2019-01-31 | 재확인 | Needham | Buy |
2019-01-02 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
2018-10-09 | 개시 | UBS | Neutral |
2018-09-13 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
모두보기
홀로직 주식(HOLX)의 최신 뉴스
Hologic stock touches 52-week low at $70.5 amid market shifts - Investing.com
Hologic (NASDAQ:HOLX) Hits New 52-Week LowTime to Sell? - MarketBeat
Hologic stock touches 52-week low at $70.5 amid market shifts By Investing.com - Investing.com South Africa
Hologic, Inc. (NASDAQ:HOLX) Shares Acquired by Franklin Resources Inc. - MarketBeat
Here's Why Hologic (HOLX) Fell More Than Broader Market - Yahoo Finance
Problems With Recalled BioZorb Markers Could Cause Severe Injury or Death, FDA Warns - AboutLawsuits.com
Needham & Company LLC Reiterates "Buy" Rating for Hologic (NASDAQ:HOLX) - MarketBeat
Hologic agrees with CDC to develop reagents for H5N1 bird flu testing - Yahoo Finance
Hologic recalls BioZorb Marker over safety concerns - MSN
Hologic's SWOT analysis: women's health tech firm faces growth challenges By Investing.com - Investing.com South Africa
Hologic's SWOT analysis: women's health tech firm faces growth challenges - Investing.com India
Hologic recalls BioZorb Marker over safety concerns (HOLX:NASDAQ) - Seeking Alpha
Hologic Inc. stock outperforms competitors despite losses on the day - MarketWatch
Hologic Inks Deal with CDC for H5N1 Bird Flu Test Development - MPO-mag
Peering Into Hologic's Recent Short Interest - Benzinga
Hologic to Contribute to H5N1 Bird Flu Test Development via Agreement Issued by CDCHologic, Inc. - Hologic, Inc. - Investor Relations
Hologic Partners with CDC to Combat Bird Flu Crisis: Develops H5N1 Detection System - StockTitan
Danbury corporate building sold for $7 million to firm founded by combat hero and Navy commander - Greenwich Time
Digital Breast Tomosynthesis Equipment Market Is Booming - openPR
Hologic Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Body Fat Measurement Devices Market Forecasted CAGR 6.3%, - openPR
Breast Cancer Core Needle Biopsy Market Top PlayersIntact - openPR
Hologic (NASDAQ:HOLX) Research Coverage Started at Wolfe Research - Defense World
FY2025 EPS Estimates for Hologic Raised by Leerink Partnrs - MarketBeat
13,629 Shares in Hologic, Inc. (NASDAQ:HOLX) Acquired by Oddo BHF Asset Management Sas - MarketBeat
Hologic, Inc. (NASDAQ:HOLX) Sees Significant Increase in Short Interest - MarketBeat
Hologic, Inc. (NASDAQ:HOLX) Shares Acquired by Toronto Dominion Bank - MarketBeat
Hologic initiated with a Peer Perform at Wolfe amid near-term headwinds - Yahoo Finance
Wolfe Research Initiates Coverage of Hologic (HOLX) with Peer Perform Recommendation - MSN
Hologic, Inc. (NASDAQ:HOLX) Shares Sold by Retirement Systems of Alabama - MarketBeat
Hologic (HOLX) Stock Moves -1.93%: What You Should Know - Yahoo Finance
Hologic Inc. stock underperforms Friday when compared to competitors - MarketWatch
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It - MSN
Hologic (NASDAQ:HOLX) Now Covered by Wolfe Research - MarketBeat
BioZorb Lawuit LawyerBreast Biopsy Marker RecallDecember 2024 Update - Levin Papantonio
XTX Topco Ltd Takes Position in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Geode Capital Management LLC Purchases 13,812 Shares of Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Barclays PLC Acquires 231,578 Shares of Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Public Employees Retirement System of Ohio Has $9.58 Million Stock Position in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Hologic Beats on Both Top and Bottom Lines - AOL
Hologic Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Hologic's SWOT analysis: diagnostics firm faces growth challenges - Investing.com
Hologic (NASDAQ:HOLX) Upgraded to Strong-Buy at BNP Paribas - MarketBeat
Nomura Asset Management Co. Ltd. Grows Position in Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Hologic Trades at 17.62X P/E: Should You Buy, Sell or Hold the Stock? - Yahoo Finance
24,363 Shares in Hologic, Inc. (NASDAQ:HOLX) Acquired by Y Intercept Hong Kong Ltd - MarketBeat
Aesthetic Medicine Market Opportunities and Key Growth - openPR
Hologic, Inc. (NASDAQ:HOLX) Shares Sold by Wellington Management Group LLP - MarketBeat
Hologic, Inc. (NASDAQ:HOLX) Shares Purchased by National Bank of Canada FI - MarketBeat
EP Wealth Advisors LLC Buys Shares of 9,956 Hologic, Inc. (NASDAQ:HOLX) - MarketBeat
Why Is Hologic Inc. (HOLX) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now? - MSN
홀로직 (HOLX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):